Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/01/2004 | CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof |
12/01/2004 | CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release |
12/01/2004 | CN1177864C Novel human protein with expression difference in liver cancer tissue and its coding sequence |
12/01/2004 | CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
11/30/2004 | US6825334 Interleukin-2 (il-2) for drugs/drug screening; genetic engineering; mitogen-activated protein kinases (map-k) |
11/30/2004 | US6825332 Gene related to migraine in man |
11/30/2004 | US6825326 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds |
11/30/2004 | US6825325 Fusion proteins; membrane anchoring; genetic engineering; kits |
11/30/2004 | US6825324 Antibodies to receptor protein tyrosine kinases |
11/30/2004 | US6825322 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
11/30/2004 | US6825008 Expressed ligand—vascular intercellular signalling molecule |
11/30/2004 | US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids |
11/30/2004 | US6825006 Preparing an insect-resistant plant, genetic engineered insecticides, crystal protein from culturing the cells, encoding endotoxins having insecticidal activity |
11/30/2004 | US6824997 For diagnosis of pneumonia/bronchitis/otitis media/sinusitis/meningitis using sample fluids (urine/blood/cerebrospinal fluid) |
11/30/2004 | US6824993 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer |
11/30/2004 | US6824989 Screening/detection of disease for diagnosis/research; genetic engineering; electrophoresis |
11/30/2004 | US6824973 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
11/30/2004 | US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
11/30/2004 | US6824781 Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist |
11/30/2004 | US6824780 Anti-tumor antibody compositions and methods of use |
11/30/2004 | US6824779 Methods for inhibiting the interaction of B7-2 with its natural ligand |
11/30/2004 | US6824778 Antibody for use in the prevention and treatment of viral diseases |
11/30/2004 | US6824777 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
11/30/2004 | US6824775 88kDa tumorigenic growth factor and antagonists |
11/30/2004 | US6824774 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination |
11/30/2004 | US6824773 TWEAK receptor |
11/30/2004 | CA2267072C Reconstituted human anti-hm1.24 antibody |
11/30/2004 | CA2239099C Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
11/30/2004 | CA2144081C Protection against liver damage by hgf |
11/30/2004 | CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics |
11/25/2004 | WO2004102199A2 Method for selecting and producing vaccine components and vaccines based thereon |
11/25/2004 | WO2004102198A2 Selection of b cells with specificity of interest: method of preparation and use |
11/25/2004 | WO2004101790A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
11/25/2004 | WO2004101777A1 A recombinant virus comprising an intact tumor-therapeutic antibody with human costant regions and the use thereof |
11/25/2004 | WO2004101762A2 Detection and treatment of cancers of the colon |
11/25/2004 | WO2004101756A2 Ovr110 antibody compositions and methods of use |
11/25/2004 | WO2004101750A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
11/25/2004 | WO2004101740A2 Clotting factor-fc chimeric proteins to treat hemophilia |
11/25/2004 | WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
11/25/2004 | WO2004101738A2 Domain-exchanged binding molecules, methods of use and methods of production |
11/25/2004 | WO2004101622A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats 06 of pseudomonas aeruginosa |
11/25/2004 | WO2004101621A1 A SPECIFIC IMMUNOGLOBULIN (Ig) Y AGAINST SEVERVE ACUTE RTESPIRATORY SYNDROME (SARS) AND A PREPARING METHOD THEREOF AND COMBINATION PREPARATIOS CONTAINING IT |
11/25/2004 | WO2004101612A2 Thioredoxin-peroxidase of c. albicans as a virulence-specific marker |
11/25/2004 | WO2004101511A2 Anti-ip-10 antibodies and methods of using thereof for the treatment of inflamatory bowel diseases |
11/25/2004 | WO2004100976A1 Klotho protein, anti-klotho protein antibody and use thereof |
11/25/2004 | WO2004100951A1 Diabetic neuropathy diagnostic and therapeutic |
11/25/2004 | WO2004100898A2 Therapeutic use of anti-cs1 antibodies |
11/25/2004 | WO2004093662A3 Method for detecting prognosis of cancer |
11/25/2004 | WO2004091511A3 Compositions and methods to diagnose and treat lung cancer |
11/25/2004 | WO2004087216A3 Genetic immunization by means of multiple expression structures in order to produce monoclonal antibodies |
11/25/2004 | WO2004087200A3 Vaccine and serum for protection of cystic fibrosis patients against pseudomonas aeruginosa |
11/25/2004 | WO2004085479A3 Treatment of viral infections |
11/25/2004 | WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity |
11/25/2004 | WO2004083387A3 Anti-ganglioside antibodies and methods of use |
11/25/2004 | WO2004080420A3 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
11/25/2004 | WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
11/25/2004 | WO2004071443A3 Methods and compositions for modulating stem cells |
11/25/2004 | WO2004067567A3 Anti-dengue virus antibodies, compositions, methods and uses |
11/25/2004 | WO2004065423A3 Recognition molecules for the treatment and detection of tumours |
11/25/2004 | WO2004064724A3 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
11/25/2004 | WO2004062462A3 Monclonal anitbodies to rna binding protein gw182 |
11/25/2004 | WO2004053063A3 Molecular determinants of myeloma bone disease and uses thereof |
11/25/2004 | WO2004037209A3 METHODS TO PREVENT TUMOR RECURRENCE BY BLOCKADE OF TGF-β |
11/25/2004 | WO2003050260A3 Streptavidin expressed gene fusions and methods of use thereof |
11/25/2004 | US20040237125 Transforming hypermutable cells with vectors coding immunoglobulin gene sequences and generating antibodies which enhanced pharmacokinetic profiles; immunotherapy |
11/25/2004 | US20040237124 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy |
11/25/2004 | US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders |
11/25/2004 | US20040236080 Particularly having antibody-dependent cell-mediated cytotoxicity activity or complement-dependent cytotoxicity activity, used for treating cancer |
11/25/2004 | US20040236079 IgG antibody, including a F(ab)'2 fragment, that induces platelet fragmentation and reacts with platelet epitope GPIIIa49-66 on platelet membranes |
11/25/2004 | US20040236078 Binds p185HER2 and has a framework region (FR) substitution at a VH71, VH73, VH78, VH93, or VL66 FR position; has the low immunogenicity of huMAb4D5-8 upon repeated administration to treat breast cancer |
11/25/2004 | US20040236077 Capable of specifically reacting with the N-terminal region of a partial peptide in a polypeptide with a specific amino acid sequence, used for diagnosis of pregnancy |
11/25/2004 | US20040236075 Novel glass II cytokine receptors, and uses thereof |
11/25/2004 | US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection |
11/25/2004 | US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
11/25/2004 | US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
11/25/2004 | US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration |
11/25/2004 | US20040235729 Complementarity-determining region; monoclonal antibodies; antiidiotypic antibodies; autoantibodies; heavy chains; light chains; polypeptides; amino acid sequences; DNA; carriers; use for treatment of systemic lupus erythematosus in humans |
11/25/2004 | US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
11/25/2004 | US20040235173 Production of host cells containing multiple integrating vectors by serial transduction |
11/25/2004 | US20040235118 Portions of soluble recombinant botulinum toxins |
11/25/2004 | US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases |
11/25/2004 | US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
11/25/2004 | US20040235113 18 human secreted proteins |
11/25/2004 | US20040235109 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/25/2004 | US20040235108 Immunoglobulin which competitively binds tetrameric form of the alpha-folate receptor for use in treatment and prevention of cell proliferfative disorders; immunotherapy |
11/25/2004 | US20040235104 Nucleotide sequences coding similar expression of fibroblast growth factors genes (SEF) for use as tools in identifying modulators of cardiovascular, urogenital and cell proliferative disorders |
11/25/2004 | US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders |
11/25/2004 | US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
11/25/2004 | US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases |
11/25/2004 | US20040235083 Screening method |
11/25/2004 | US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies |
11/25/2004 | US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer |
11/25/2004 | US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy |
11/25/2004 | US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
11/25/2004 | US20040235058 ULBP antibodies |
11/25/2004 | US20040235047 Therapeutic agent comprising cytokine inhibitory activity for use in treatment of respiratory system disorders; viricides; antisense agents; enzyme inhibitors; immunotherapy; RNA interference; recombinant cytokine receptors |
11/25/2004 | US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders |
11/25/2004 | US20040235020 Methods for monitoring drug activities in vivo |
11/25/2004 | US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents |
11/25/2004 | US20040235011 Production of multimeric proteins |